OMNICEF 300 mg a (Omnicef 300 mg)
Generic Name: cefdinir
Pill with imprint OMNICEF 300 mg a is Purple / Green, Capsule-shape and has been identified as Omnicef 300 mg. It is supplied by Abbott Laboratories.
Omnicef is used in the treatment of sinusitis; otitis media; pneumonia; bronchitis; skin and structure infection and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Omnicef 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OMNICEF 300 mg a
Omnicef
- Generic Name
- cefdinir
- Imprint
- OMNICEF 300 mg a
- Strength
- 300 mg
- Color
- Purple / Green
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Third generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Abbott Laboratories
- National Drug Code (NDC)
- 00074-3769 (Discontinued)
More about Omnicef (cefdinir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 48 Reviews
- Generic Availability
- Drug class: third generation cephalosporins
Patient resources
- Drug Information
- Omnicef (Advanced Reading)
- Omnicef (Cefdinir Capsules)
- Omnicef (Cefdinir Suspension)
- Other brands
- Omnicef Omni-Pac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.